Peri-operative Morbidity of Nissen Sleeve Gastrectomy: Prospective Evaluation of a Cohort of 365 Patients, Beyond the Learning Curve.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
07 2022
Historique:
received: 20 01 2022
accepted: 13 04 2022
revised: 10 04 2022
pubmed: 8 5 2022
medline: 15 7 2022
entrez: 7 5 2022
Statut: ppublish

Résumé

Over the last decade, an important interest was taken to prevent the reflux following sleeve. A new variant, Nissen-sleeve, was described with the purpose to prevent GERD and to decrease the occurrence of leak. The current study reports the preliminary results of a prospective trial. All consecutive patients who underwent a Nissen-Sleeve between January 2018 and September 2020 were included. Baseline characteristics including age, gender, weight, body mass index (BMI), GERD symptoms, and treatment were evaluated after 1 year. Operative time, length of stay, complication, and reoperation data were also collected. Three hundred sixty-five consecutive patients decided to undergo Nissen-sleeve: 75% females with median age of 41.2 years (+ / - 14.1) and an average BMI of 41.6 kg/m Following the initial learning curve and additional technical modifications, the Nissen-Sleeve appears to be a safe surgical technique with an acceptable early postoperative complication rate. NCT02310178.

Identifiants

pubmed: 35524904
doi: 10.1007/s11695-022-06066-0
pii: 10.1007/s11695-022-06066-0
doi:

Banques de données

ClinicalTrials.gov
['NCT02310178']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31(5):1937–48.
doi: 10.1007/s11695-020-05207-7
Higa K, Ho T, Tercero F, Yunus T, Boone KB. Laparoscopic Roux-en-Y gastric bypass 10-year follow-up. Surg Obes Relat Dis. 2011;20117(4):516–25.
doi: 10.1016/j.soard.2010.10.019
Fezzi M, Kolotkin RL, Nedelcu M, et al. Improvement in quality of life after laparoscopic sleeve gastrectomy. Obes Surg. 2011;21(8):1161–7.
doi: 10.1007/s11695-011-0361-x
Arman GA, Himpens J, Dhaenens J, Ballet T, Vilallonga R, Leman G. Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778–86.
doi: 10.1016/j.soard.2016.01.013
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.
doi: 10.1016/j.soard.2016.11.029
Sebastianelli L, Benois M, Vanbiervliet G, Bailly L, Robert M, Turrin N, Gizard E, Foletto M, Bisello M, Albanese A, Santonicola A, Iovino P, Piche T, Angrisani L, Turchi L, Schiavo L, Iannelli A. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg. 2019;29(5):1462–9.
doi: 10.1007/s11695-019-03704-y
Felsenreich DM, Kefurt R, Schermann M, Beckerhinn P, Kristo I, Krebs M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101.
doi: 10.1007/s11695-017-2748-9
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21(36):10348–57.
doi: 10.3748/wjg.v21.i36.10348
Mahawar KK, Carr WRJ, Jennings N, Balupuri S, Small PK. Simultaneous sleeve gastrectomy and hiatus hernia repair: a systematic review. Obes Surg. 2015;25(1):159–66.
doi: 10.1007/s11695-014-1470-0
Soricelli E, Iossa A, Casella G, Abbatini F, Calì B, Basso N. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg Obes Relat Dis May-Jun. 2013;9(3):356–61.
doi: 10.1016/j.soard.2012.06.003
Samakar K, McKenzie TJ, Tavakkoli A, Vernon AH, Robinson MK, Shikora SA. The effect of laparoscopic sleeve gastrectomy with concomitant hiatal hernia repair on gastroesophageal reflux disease in the morbidly obese. Obes Surg. 2016;26(1):61–6.
doi: 10.1007/s11695-015-1737-0
Nocca D, Skalli EM, Boulay E, Nedelcu M, Michel Fabre J, Loureiro M. Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study. Surg Obes Relat Dis. 2016;12(10):1832–7.
doi: 10.1016/j.soard.2016.02.010
Weiss AC, Parina R, Horgan S, Talamini M, Chang DC, Sandler B. Quality and safety in obesity surgery-15 years of Roux-en-Y gastric bypass outcomes from a longitudinal database. Surg Obes Relat Dis. 2016;12(1):33–40.
doi: 10.1016/j.soard.2015.04.018
Olmi S, Cesana G, D’Angiolella L, Bonaldi M, Uccelli M, Mantovani L. Sleeve gastrectomy with tailored 360 fundoplication according to Rossetti in patients affected by obesity and gastroesophageal reflux: a prospective observational study. Surg Obes Relat Dis. 2021;17(6):1057–65.
doi: 10.1016/j.soard.2021.01.007
Gagner M, Kemmeter P. Comparison of laparoscopic sleeve gastrectomy leak rates in five staple-line reinforcement options: a systematic review. Surg Endosc. 2020;34(1):396–407.
doi: 10.1007/s00464-019-06782-2
Salminen P, Helmio M, Ovaska J, et al. Effect of Laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS Randomized Clinical Trial. JAMA. 2018;319(3):241–54.
doi: 10.1001/jama.2017.20313
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS Randomized Clinical Trial. JAMA. 2018;319(3):255–65.
doi: 10.1001/jama.2017.20897

Auteurs

David Nocca (D)

CHU de Montpellier, CHU Saint Eloi 80 Av Augustin FlicheCedex 5, 34295, Montpellier, France. d-nocca@chu-montpellier.fr.
Institut de Génomique Fonctionnelle, UMR 5203 CNRS- U1191, INSERM- Univ Montpellier, Montpellier, France. d-nocca@chu-montpellier.fr.

Florence Galtier (F)

CHU de Montpellier, CHU Saint Eloi 80 Av Augustin FlicheCedex 5, 34295, Montpellier, France.
Inserm CIC 1411, Montpellier, France.

Sulaiman Taleb (S)

CHU de Montpellier, CHU Saint Eloi 80 Av Augustin FlicheCedex 5, 34295, Montpellier, France.

Marie-Christine Picot (MC)

Institut de Génomique Fonctionnelle, UMR 5203 CNRS- U1191, INSERM- Univ Montpellier, Montpellier, France.
Inserm CIC 1411, Montpellier, France.
Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France.

Audrey Jaussent (A)

Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France.

Marta Silvestri (M)

Clinique Clémentville, Montpellier, France.

Patrick Lefebvre (P)

CHU de Montpellier, CHU Saint Eloi 80 Av Augustin FlicheCedex 5, 34295, Montpellier, France.

Audrey de Jong (A)

CHU de Montpellier, CHU Saint Eloi 80 Av Augustin FlicheCedex 5, 34295, Montpellier, France.

Thomas Gautier (T)

Clinique Saint Jean Sud de France, Montpellier, France.

Marcelo Loureiro (M)

CHU de Montpellier, CHU Saint Eloi 80 Av Augustin FlicheCedex 5, 34295, Montpellier, France.
Universidade Positivo, Curitiba, Brazil.

Marius Nedelcu (M)

ELSAN Clinique Bouchard, Marseille, France.
ELSAN Clinique Saint Michel, Toulon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH